Atezolizumab Alone or With Bevacizumab vs Sunitinib in Previously Untreated mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Patient-Reported Outcomes in a Phase 2 Study Comparing Atezolizumab Alone or With Bevacizumab Versus Sunitinib in Previously Untreated Metastatic Renal Cell Carcinoma
BJU Int 2020 Mar 31;[EPub Ahead of Print], SK Pal, DF McDermott, MB Atkins, B Escudier, BI Rini, RJ Motzer, L Fong, RW Joseph, S Oudard, A Ravaud, S Bracarda, C Suarez, ET Lam, TK Choueiri, B Ding, C Quach, K Hashimoto, C Schiff, E Piault-Louis, T PowlesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.